X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
psoriasis (18) 18
dermatology (16) 16
humans (9) 9
infliximab (8) 8
dermatologic agents (7) 7
formulae, receipts, prescriptions (7) 7
male (7) 7
care and treatment (6) 6
clinical trials (6) 6
medical research (6) 6
medicine, experimental (6) 6
monoclonal antibodies (6) 6
patients (6) 6
tumor necrosis factor-α (6) 6
adult (5) 5
female (5) 5
infections (5) 5
methotrexate (5) 5
middle aged (5) 5
skin (5) 5
esters (4) 4
fumaric acid (4) 4
health aspects (4) 4
psoriasis - drug therapy (4) 4
retinoids (4) 4
risk factors (4) 4
analysis (3) 3
biological factors - adverse effects (3) 3
etanercept (3) 3
intravenous administration (3) 3
prospective studies (3) 3
psoriasis - epidemiology (3) 3
quality of life (3) 3
adolescent (2) 2
age of onset (2) 2
aged (2) 2
antibiotics (2) 2
antibodies, monoclonal - adverse effects (2) 2
article (2) 2
cardiac patients (2) 2
cardiovascular diseases (2) 2
cohort (2) 2
comorbidity (2) 2
dk/atira/pure/subjectarea/asjc/2700/2708 (2) 2
double-blind (2) 2
health risk assessment (2) 2
interleukin-12/23 monoclonal-antibody (2) 2
interleukins (2) 2
placebo-controlled trial (2) 2
prediction models (2) 2
registries (2) 2
rheumatoid-arthritis (2) 2
severe plaque psoriasis (2) 2
systematic review (2) 2
therapy (2) 2
to-severe psoriasis (2) 2
tumor necrosis factor-alpha - antagonists & inhibitors (2) 2
tumors (2) 2
united kingdom - epidemiology (2) 2
young adult (2) 2
abnormalities, drug-induced - etiology (1) 1
acne conglobata - drug therapy (1) 1
adalimumab - therapeutic use (1) 1
adalimumab use (1) 1
adults (1) 1
adverse events (1) 1
age (1) 1
alcohol (1) 1
alcoholic beverages (1) 1
anti-inflammatory agents - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
arthritis (1) 1
badbir, british association of dermatologists biologic interventions register (1) 1
bias (1) 1
biologic therapies (1) 1
biological factors - therapeutic use (1) 1
biological products (1) 1
biological therapy - adverse effects (1) 1
biologics (1) 1
body mass index (1) 1
body-mass index (1) 1
breast feeding (1) 1
breast-milk (1) 1
breastfeeding & lactation (1) 1
british association (1) 1
buschke-lowenstein tumour (1) 1
buschke–lowenstein tumour (1) 1
calibration (1) 1
carcinoma, hepatocellular - drug therapy (1) 1
cardiovascular diseases - chemically induced (1) 1
case reports (1) 1
cd4-cd8 ratio (1) 1
cell count (1) 1
cells (1) 1
cerebrovascular system (1) 1
chinese patients (1) 1
chronic infection (1) 1
ci, confidence interval (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Dermatology, ISSN 0007-0963, 03/2017, Volume 176, Issue 3, pp. 566 - 567
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2018, Volume 179, Issue 2, pp. 239 - 240
Linked Article: Gether et al. Br J Dermatol 2018; 179:282–289. 
CLASSIFICATION | DERMATOLOGY | Epidemiology | Rosacea
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 06/2019, Volume 180, Issue 6, pp. e242 - e242
Summary Psoriasis is a skin condition that causes a scaly, red rash which can vary from affecting only small areas of the body, such as the elbows and knees,... 
Medicine, Experimental | Medical research | Dermatologic agents | Psoriasis | Dermatology | Formulae, receipts, prescriptions | Knee | Tablets | Clinical trials | Skin | Patients | Immune system
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 06/2019, Volume 180, Issue 6, pp. e259 - e259
Summary 银屑病是一种导致鳞片状、红疹的皮肤病,其受累部位从仅小面积(如肘关节和膝关节)到更大面积不等。在英国约2%的人患有银屑病。该疾病有许多治疗方法,包括药膏、片剂和注射剂。注射剂称为生物制剂,免疫系统的这种靶向特异性成分对银屑病非常有效。本文的英国作者旨在评估两项比较两种这类生物制剂... 
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 04/2017, Volume 176, Issue 4, pp. 890 - 901
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 06/2019, Volume 180, Issue 6, pp. 1348 - 1351
Summary Aim Gordon et al. investigated the efficacy and safety of risankizumab [an anti‐interleukin (IL)‐23p19 biologic] compared with ustekinumab... 
Psoriasis | Interleukins | Clinical trials | Tumor necrosis factor | Quality of life | Tumors
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 04/2019, Volume 180, Issue 4, pp. e138 - e138
Summary 这项研究由一组来自曼彻斯特和汉堡的皮肤科研究者执行。它使用来自德国银屑病登记数据库和英国皮肤病学会生物干预登记数据库(或... 
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 04/2019, Volume 180, Issue 4, pp. e122 - e122
Journal Article
Clinical and Experimental Dermatology, ISSN 0307-6938, 06/2015, Volume 40, Issue 4, pp. 383 - 386
Summary Acne conglobata (AC) is a chronic, severe, inflammatory variant of acne characterized by development of cystic nodules, abscesses and sinus tracts. AC... 
Adalimumab - therapeutic use | Humans | Acne Conglobata - drug therapy | Anti-Inflammatory Agents - therapeutic use | Adult | Male | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2019, Volume 180, Issue 2, pp. e46 - e46
Summary This study from the UK used information from a data source known as the British Association of Dermatologists Biologic Interventions Register, or... 
Tuberculosis | Intravenous administration | Psoriasis | Antibiotics | Infliximab | Monoclonal antibodies | Chronic infection | Skin diseases | Infections | Skin | Tumor necrosis factor-α | Patients
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 02/2019, Volume 180, Issue 2, pp. e59 - e59
Summary 这项英国研究使用的信息来自一个名为“英国皮肤科医师协会生物干预注册数据库”(British Association of Dermatologists Biologic Interventions Register,或称... 
Psoriasis | Infliximab | Infections
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2019, Volume 181, Issue 2, pp. e55 - e55
Summary... 
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 08/2019, Volume 181, Issue 2, pp. e45 - e45
Summary The health watchdog NICE recommends that patients with moderate‐to‐severe psoriasis should try at least two non‐biologic systemic therapies before they... 
Medical research | Care and treatment | Psoriasis | Dermatology | Esters | Dermatologic agents | Cyclosporine | Retinoids | Fumaric acid | Analysis | Formulae, receipts, prescriptions | Medicine, Experimental | Methotrexate | Toxicity | Scaling | Patients
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2019, Volume 181, Issue 6, pp. 1265 - 1271
Summary Background Patients recruited in randomized controlled trials (RCTs) for biologic therapies in psoriasis are not fully representative of the real‐world... 
Clinical trials | Population | Psoriasis | Immunomodulation | Patients | Standardization | Original | General Dermatology
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 11/2016, Volume 175, Issue 5, pp. 1038 - 1044
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 12/2017, Volume 177, Issue 6, pp. 1766 - 1767
Conflicts of interest: R.B.W. has acted as a consultant and/or speaker for and/or received research grants for Abbvie, Amgen, Celgene, Eli Lilly, Pfizer,... 
DERMATOLOGY | Care and treatment | Psoriasis | Cardiac patients | Risk factors | Clinical trials | Cardiovascular diseases
Journal Article